{"name":"Myungmoon Pharma. Co. Ltd.","slug":"myungmoon-pharma-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-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?oc=5","date":"2025-12-22","type":"pipeline","source":"businesswire.com","summary":"$922 Million Motion Sickness Treatment Market Outlook, 2025-2032: Growth of Personalized Motion Sickness Management Plans Leveraging AI Driven Symptom Tracking Mobile Applications - ResearchAndMarkets","headline":"$922 Million Motion Sickness Treatment Market Outlook, 2025-2032: Growth of Personalized Motion Sickness Management Plan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPcEJlUEZMbl82M2FzeTFvNEVhaVota1ZKckd2S0ZxZUlsOUdVWVQ2TDR6UjRKVzRJOVM2S25qbVItNklYN1FBUFV3eDFpMTRCTmNVZGEzU2FxMk1GaXdDVElSSTdVVTFDeVVodXZaUVg3WjBEQ0ltTlFKRUpYSENhVnhLZWFFLTBwMEJGaGN3?oc=5","date":"2024-12-18","type":"pipeline","source":"Yahoo Finance","summary":"The Global Market for Motion Sickness Treatment, 2024-2030: Increasing Preference for OTC Solutions Strengthens Business Case - Yahoo Finance","headline":"The Global Market for Motion Sickness Treatment, 2024-2030: Increasing Preference for OTC Solutions Strengthens Business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFA5RnZiUFhLdHEwY2o4TEtVd2xobXdaTFFuQ2NEZzRqU2FEVnJkQ2JyRjROM0Q0cnFMLU83QkV6QlE4eTk2N2xURkdBVE1qdm9xQ2dCNGhTRUIxYXhQTW82djYyXzh5SXloOXd5eF9B0gFyQVVfeXFMUEs0cDB2NWNnRk0xR19HU0dmWkFaWjJDbm9HSXNMZHdnRlk3dVBuV1R5dVQzTk0yLXl6OUFmM3J2X01YMjVqTnA2TzFKRjNfdTJ5QmJHa1NUbEN1VDJ6UWhZdm84VUdqbWpRTXp6WHpaRDl3?oc=5","date":"2023-10-11","type":"pipeline","source":"koreabiomed.com","summary":"New drug mispackaging incident hits 2 pharma firms - koreabiomed.com","headline":"New drug mispackaging incident hits 2 pharma firms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxNTEVUNVdPeU96b0FXTXZ6LVNBQUpwQ2xVNTdIVFMxcWlidW5yQ3BPUmNKTGlHNzRLTHE1M2FrYklQSndvZ0hNc2FwdUFNVDVHS09WSUJ6RnJDWW9nYTVMdm1OajdxMDhGc2NJU2hjck5ONVFmcW9nWnN6ZFFuRE82UDZTQkNrR1Jfa2tmdkVQbURXTks4cFFjMkVjeWNGVUtMa29pdi1TOEpLbTVuRWRrY2thVmlzb0pxUDlPZzVqbnNrV3hvMTJxZW4wbE9qRUU4Y3VnSmM2R1lQcTVrQlBvVmJWRXJVaUxibHBiY2pJNA?oc=5","date":"2018-07-18","type":"pipeline","source":"GlobeNewswire","summary":"Global Scopolamine Market to Surpass US$ 563.3 Million by 2026 – Coherent Market Insights - GlobeNewswire","headline":"Global Scopolamine Market to Surpass US$ 563.3 Million by 2026 – Coherent Market Insights","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}